An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, further providing for coverage for colorectal cancer screening.

Updated the required screening guidelines from the American Cancer Society (2018) to 'Approved Medical Guidelines,' which now include the American Cancer Society, National Comprehensive Cancer Network, and CMS guidelines.

Added coverage for Multi-Target Stool RNA tests and Cell-Free DNA or other blood-based screening tests every three years.

Clarified that coverage for high-risk individuals under 45 must follow U.S. Multi-Society Task Force recommendations rather than just American Cancer Society guidelines.

Added a new definition for 'Approved Medical Guidelines' listing specific organizations and publication dates to guide future updates.

Updated the definition of 'Direct Visualization Test' to include CT colonography and other visual observation methods.

Extended the application timeline for policies not requiring federal filing to 180 days after the effective date.